
    
      Purpose: to evaluate the efficacy and toxicity of a concomitant treatment using EGFR-TKI and
      thoracic radiation in elderly patients with esophageal Cancer.

      Methods:Patients(>70 years old) with esophageal Cancer will receive thoracic radiation
      therapy 54-60 Gy over 30 fractions and concurrent with gefitinib 250mg/day.
    
  